These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22752797)

  • 1. Personalized medicine using DNA biomarkers: a review.
    Ziegler A; Koch A; Krockenberger K; Grosshennig A
    Hum Genet; 2012 Oct; 131(10):1627-38. PubMed ID: 22752797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
    Seo MK; Cairns J
    BMC Cancer; 2021 Sep; 21(1):980. PubMed ID: 34470603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New directions in biomarker research, drug development and personalized medicine].
    Németh G; Jelinek I
    Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic biomarkers for personalized medicine: development and validation in clinical studies.
    Matsui S
    Comput Math Methods Med; 2013; 2013():865980. PubMed ID: 23690882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.
    Barsanti-Innes B; Hey SP; Kimmelman J
    Oncologist; 2017 Jan; 22(1):89-96. PubMed ID: 28126916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and biomarker validation: a pathologist's guide to getting it right.
    Paver EC; Morey AL
    Pathology; 2024 Mar; 56(2):147-157. PubMed ID: 38195376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.
    Lin JA; He P
    Br Med Bull; 2015 Jun; 114(1):17-27. PubMed ID: 25921239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Biomarkers on Personalized Medicine.
    Carrigan P; Krahn T
    Handb Exp Pharmacol; 2016; 232():285-311. PubMed ID: 26330258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial designs for testing biomarker-based personalized therapies.
    Lai TL; Lavori PW; Shih MC; Sikic BI
    Clin Trials; 2012 Apr; 9(2):141-54. PubMed ID: 22397801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
    Benincasa G; Mansueto G; Napoli C
    J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology.
    Landeck L; Kneip C; Reischl J; Asadullah K
    Exp Dermatol; 2016 May; 25(5):333-9. PubMed ID: 27167702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Signature Program: Bringing the Protocol to the Patient.
    Kang BP; Slosberg E; Snodgrass S; Lebedinsky C; Berry DA; Corless CL; Stein S; Salvado A
    Clin Pharmacol Ther; 2015 Aug; 98(2):124-6. PubMed ID: 25810246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study designs and statistical analyses for biomarker research.
    Gosho M; Nagashima K; Sato Y
    Sensors (Basel); 2012; 12(7):8966-86. PubMed ID: 23012528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
    Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
    Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
    Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
    Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision medicine needs randomized clinical trials.
    Saad ED; Paoletti X; Burzykowski T; Buyse M
    Nat Rev Clin Oncol; 2017 May; 14(5):317-323. PubMed ID: 28169302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study designs and patient selection methods based on genomic biomarkers: Points-to-consider documents.
    Tohkin M; Saito Y; Yagi S; Asano K; Maekawa K; Osabe M; Iida S; Miyata N
    Drug Metab Pharmacokinet; 2020 Apr; 35(2):187-190. PubMed ID: 32007355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.